4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-24-000706
Chief Financial Officer bought 66,666 shares at $0.30 ($20,000)
From the SEC's structured data for this filing
Trades in this filing
Downs Christopher · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-01 | Purchase : show line 1 in the form | +66,666 | $0.30 | $20,000 | 103,438 | D |
| Open-market purchases · 66,666 sh · avg $0.30 · $20,000 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-01 | Grant or award : show line 2 in the form Series A Warrant to purchase common stock | +66,666 | 94,906 | D |
| 2024-02-01 | Grant or award : show line 3 in the form Series B Warrant to purchase common stock | +66,666 | 161,572 | D |
Loading xslF345X05/ownership.xml…